SpareBank 1 SR-Bank ASA

As of September 30, 2024, SpareBank 1 SR-Bank ASA has 264.22M shares outstanding.

As of September 30, 2024, SpareBank 1 SR-Bank ASA trades at a trailing price-to-earnings ratio of 6.78. The price-to-sales ratio is 3.92, and the price-to-book ratio stands at 5.44.

These figures are as of September 30, 2024. The EV/Sales ratio of 24.09 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. SpareBank 1 SR-Bank ASA trades at an EV/FCF ratio of 74.79, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

These figures are as of September 30, 2024.

Over the twelve months ended September 30, 2024, SpareBank 1 SR-Bank ASA posted a return on equity (ROE) of 81.62, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 1.43, measuring how efficiently the asset base is converted into earnings.

These figures cover the twelve months ended September 30, 2024. That works out to an effective tax rate of 18.23, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended September 30, 2024, SpareBank 1 SR-Bank ASA posted a gross margin of 100.00, reflecting its pricing power and cost economics.

These figures cover the twelve months ended September 30, 2024. Free cash flow yield is negative at -6.91: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -12.73, meaning SpareBank 1 SR-Bank ASA raised more capital through share issuance and new debt than it returned via dividends and buybacks.

SpareBank 1 SR-Bank ASA's most recent stock split took place on May 10, 2012 with a 125:133 split ratio.

As of September 30, 2024, SpareBank 1 SR-Bank ASA has an Altman Z-Score of 0.09, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.